US EditionNIH funding cuts have affected over 74,000 people enrolled in experiments, a new report says
NIH grant cuts led to the termination of 383 trials, impacting treatment for diseases including cancer and infectious illnesses, affecting over 74,000 participants, according to JAMA Internal Medicine.
- Over 74,000 people enrolled in experiments were affected by National Institutes of Health's funding cuts.
- The cuts impacted efforts to tackle infectious diseases like flu, pneumonia and COVID-19.
- The lost research harms patients who could have benefited from possible new treatments, researchers said.
75 Articles
75 Articles
Hundreds of Cancer, Infectious Disease Trials Disrupted by NIH Cuts
More than 380 clinical trials and tens of thousands of participants were disrupted by cuts to grant funding from the National Institutes of Health this year, according to a research analysis published Monday by JAMA Internal Medicine.
NIH grant cuts leave hundreds of clinical trials, 74,000 patients in limbo, study finds - The Boston Globe
Trials on prevention and infectious-disease, as well as those conducted outside the United States, were the hardest hit among the more than 380 affected studies.
NIH funding cuts have impacted more than 74,000 people enrolled in trials: Report
More than 74,000 people have had their lives disrupted by Trump administration cuts to clinical trials supported by the National Institutes of Health (NIH), according to a report released Monday. From the end of February to August, the administration’s unprecedented broadside against the NIH resulted in funding losses for 383 clinical trials, new research published in the journal JAMA Internal Medicine found. The…
Coverage Details
Bias Distribution
- 49% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
